Testicular Cancer Information Center
Each year in the United States, more than 8000 men are diagnosed with testicular cancer. Thanks to improvements in treatment, however, testicular cancer patients are living longer. It is estimated that there are more than 184,000 testicular cancer survivors in the U.S. today.
Advances in surgery, chemotherapy, and radiation therapy have contributed to improved testicular cancer survival. In addition, advances in supportive care have made testicular cancer treatment more tolerable, leading to improved quality of life.
Understanding testicular cancer treatment options, the role of different doctors specializing in the treatment of testicular cancer, and how and when to access new and innovative testicular cancer treatment options available through clinical trials is essential in order to achieve the best outcome from testicular cancer treatment.
The Cancer Consultants Testicular Cancer Information Center has been designed to help patients understand testicular cancer and testicular cancer treatment options while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of testicular cancer.
Headline Testicular Cancer News 
Men with Infertility May Have Increased Risk of Testicular Cancer
Men with Infertility May Have Increased Risk of Testicular Cancer Men with infertility...
Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer
Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer Among...
Recurrent Testicular Cancer Potentially Curable with High-dose Therapy and Stem Cell Transplant
Recurrent Testicular Cancer Potentially Curable with High-dose Therapy and Stem Cell...
Testicular Cancer Tips
Managing a rare cancer One survivor shares her tips for navigating the sometimes...
Sun Safety During Cancer Treatment Shielding your skin from the sun’s potentially harmful ultraviolet rays...
Understanding the Goals of Cancer Treatment with Chemotherapy If you’ve been diagnosed with cancer, your healthcare team may have prescribed...
Testicular Cancer Management
Inspiration, Hope & Resources
On Top of the World: Climbing Everest & Beating Cancer Twice Sean Swarner is a master of setting a goal and achieving it. So when he...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Where Kids Can Be Kids… And Cancer Takes a Back Seat Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Testicular Cancer Clinical Trials
REFMAL28-Ts – A PHASE I STUDY OF ORAL TEMOZOLOMIDE IN COMBINATION WITH IRINOTECAN IN PATIENT WITH REFRACTORY AND/OR ADVANCED SOLID TUMORS.-Ts
REFMAL39 – A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Weekly for Three Consecutive Weeks of 28-Day Cycle in Patients with Solid Tumors
REFMAL30-TS – PHASE I, OPEN-LABEL, MULTI-DOSE, DOSE-ESCALATION STUDY OF GW572016 IN PATIENTS WITH SOLID TUMORS-TS
 |
 |
 |
 |
